March 14, 2018 / 10:18 AM / 9 months ago

BRIEF-CytoDyn To Amend Protocol For PRO 140 Phase 2 Trial In GVHD

March 14 (Reuters) - Cytodyn Inc:

* CYTODYN TO AMEND PROTOCOL FOR PRO 140 PHASE 2 TRIAL IN GVHD

* CYTODYN INC - ‍IDMC FOR PRO 140 PHASE 2 TRIAL IN GVHD COMPLETED PLANNED INTERIM ANALYSIS OF TRIAL DATA ON FIRST 10 PATIENTS ENROLLED​

* CYTODYN INC - BASED ON IDMC MEET, ‍PLANS TO AMEND TRIAL PROTOCOL AND TO OBTAIN CONCORDANCE FOR AMENDED PROTOCOL FROM FDA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below